Skip to content

13F-HR filed by BAILARD, INC.

BAILARD, INC. filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-04-24, with 539 holding rows worth $1,612,270,000.

Accession
0001085146-19-001242
Filed
2019-04-24
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 539 entries on the cover page, a total value of $1,612,270,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,612,270,000 with VALUE read as thousands by filing date, 13F file number 028-01707. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MTBC INC55378G102COM42,097$186,000thousands by filing date
RYERSON HLDG CORP783754104COM21,500$184,000thousands by filing date
SHORE BANCSHARES INC825107105COMMON STOCK12,300$183,000thousands by filing date
RIVERVIEW BANCORP INC769397100COM24,800$181,000thousands by filing date
VICTORY CAP HLDGS INC DEL COM CL A92645B103Stock11,936$179,000thousands by filing date
COMMERCIAL VEH GROUP INC202608105COM23,100$177,000thousands by filing date
CONSTRUCTION PARTNERS INC21044C107COM CL A13,700$175,000thousands by filing date
RADIANT LOGISTICS INC75025X100COM27,500$173,000thousands by filing date
PHOTRONICS INC719405102COM18,000$170,000thousands by filing date
TESSCO TECHNOLOGIES INC872386107COM11,000$170,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM11,000$167,000thousands by filing date
SIENTRA INC82621J105COM19,400$166,000thousands by filing date
CLARUS CORP NEW18270P109COM12,900$165,000thousands by filing date
ING GROEP N.V. SPONSORED ADR456837103ADR12,358$150,000thousands by filing date
ATLANTIC PWR CORP04878Q863COM NEW58,600$148,000thousands by filing date
BANCORP INC DEL05969A105COM18,000$145,000thousands by filing date
PROTEOSTASIS THERAPEUTICS IN74373B109COM115,000$145,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock10,500$141,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM33,000$138,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock13,200$135,000thousands by filing date
EVERI HLDGS INC30034T103COM12,500$132,000thousands by filing date
ENTERCOM COMMUNICATIONS CORP293639100CL A25,000$131,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK14,900$122,000thousands by filing date
ITAU UNIBANCO HLDG S A SPON ADR REP PFD465562106ADR12,000$106,000thousands by filing date
ACCURAY INC DEL004397105COM21,300$102,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock25,000$100,000thousands by filing date
APYX MEDICAL CORPORATION03837C106COM15,722$99,000thousands by filing date
STARRETT (L.S.) CO -CL A855668109CL A12,800$99,000thousands by filing date
ALASKA COMMUNICATIONS SYS GR01167P101COM50,410$97,000thousands by filing date
COFFEE HLDG CO INC192176105COM17,503$95,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM14,800$92,000thousands by filing date
CONSUMER PORTFOLIO SERVICES210502100COMMON STOCK25,300$88,000thousands by filing date
Cinedigm Corp CL A172406209COM NEW46,100$88,000thousands by filing date
RUBICON PROJ INC78112V102COM14,100$86,000thousands by filing date
FINJAN HLDGS INC31788H303COM NEW26,100$76,000thousands by filing date
SALEM MEDIA GROUP INC CLASS A794093104COM28,300$72,000thousands by filing date
ARDELYX INC039697107COM23,141$65,000thousands by filing date
EKSO BIONICS HLDGS INC282644202COM NEW25,100$63,000thousands by filing date
NAVIDEA BIOPHARMACEUTICALS I63937X103COM10,000$1,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-19-001242this filing2019-04-24acceptance time not in the bulk data set